Asian Spectator

Men's Weekly

.

Ushering in a Year of Prosperity: Celebrating Thailand’s Chinese New Year Festival Siam Paragon Joins Forces with TAT and Kasikornbank to Launch Siam Paragon A Prosperous Chinese New Year 2026

Showcasing Spectacular Entertainment and Chinese Cultural Performances, Featuring Renowned Chinese Artist “Zhu Zhengting” to Bless the People of Thailand in the Heart of the CityBANGKOK, ...

Blockchain Liberty for All

Washington, D.C., May 3, 2021 - (ACN Newswire) - Live from Washington DC, GBA will host a virtual gathering of members to celebrate the accomplishments of 2020 and plan our trajectory going...

Alibaba Group and the Government of Thailand Enter into Strate...

BANGKOK, April 19, 2018 /PRNewswire-AsiaNet/ -- Key initiatives include Smart Digital Hub in the EEC, training of digital talent and SMEs, smart tourism and Thai agricultural exports to Chin...

OnBoard Receives $100M Growth Investment from JMI Equity

INDIANAPOLIS, July 7, 2021 /PRNewswire-AsiaNet/ -- -- Funding to Fuel Significant Growth and Product Innovation for OnBoard, the Leading Board Intelligence Platform Focused on Digitally Tran...

Trina Storage and Power Electronics will jointly deploy over 1...

MUNICH, May 19, 2022 /PRNewswire-AsiaNet/ -- Trina Storage, the vertically integrated BESS (battery energy storage system) solutions provider, has announced the signing of the Letter of Inte...

Advanced Markets Launches UK Company

LONDON, Oct. 31, 2018 /PRNewswire-AsiaNet/ -- --FCA-Regulated Entity Encompasses New London Office and Data CenterAdvanced Markets, an institutional foreign exchange liquidity and prime-of-p...

Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors

NEW JERSEY, the U.S. and HANGZHOU, China, Sep 8, 2021 - (ACN Newswire) - Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced th...

Six S-64 Air Crane(R) Helicopters Continue Fight in Australia

PORTLAND, Oregon, Jan. 4, 2020 /PRNewswire-AsiaNet/ -- -- The Toughest Jobs Call for the Toughest AircraftErickson Incorporated, a worldwide leading operator, maintainer, and manufacturer of...

Amazon Singapore Brings Holiday Joy to the City with Amazon.sg Holiday Market from 20 November

Free public event to feature Black Friday holiday gifting deals and inspiration, holiday-themed activities including a skating rink.SINGAPORE - Media OutReach - 9 November 2023 - (NASDAQ: A...

Hitachi to Provide CNAO with Proton Therapy System

TOKYO, Dec 6, 2019 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system.

image

Centro Nazionale di Adroterapia Oncologica (National Center for Oncological Hadrontherapy for the treatment of tumors)

In the comprehensive public tender process, Hitachi has been selected to provide proton therapy systems with the latest technologies including advanced scanning technology to irradiate even tumors with complex shapes with high precision.

The agreement includes multiyear service and maintenance of the system and this will be the 1st Hitachi Proton Therapy System to be installed in Italy and the 2nd in Europe.

CNAO, located in Pavia (near Milan), Italy, is a world's leading clinical center on particle cancer therapy and the first national hadrontherapy center in Italy. CNAO was established and is operated by the CNAO Foundation, a non-profit organization fully funded by the Italian government. CNAO has started cancer treatment for proton therapy since 2011 and heavy ion therapy since 2012, and it will develop a new proton therapy facility to enhance further research and cancer treatment.

Hitachi has been proactively promoting particle therapy system business worldwide, supplying world-class facilities with its highly reliable and proven particle therapy systems, which have treated more than 60,000 patients. Hitachi will provide system and services, including single room solution in realizing installation in urban limited areas and hybrid system combined with capability of generating both proton and heavy-ion in one accelerator, to meet all customer needs.

Hitachi will contribute to the improvement of people's quality of life and social values through the global expansion of its particle therapy system business.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is focusing on Social Innovation Business combining its operational technology, information technology and products. The company's consolidated revenues for fiscal 2018 (ended March 31, 2019) totaled 9,480.6 billion yen ($85.4 billion), and the company has approximately 296,000 employees worldwide. Hitachi delivers digital solutions utilizing Lumada in five sectors including Mobility, Smart Life, Industry, Energy and IT, to increase our customer's social, environmental and economic value. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.

Copyright 2019 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Virus Nipah ditemukan di Indonesia, tapi mengapa belum ada kasus penularan pada manusia?

● Virus Nipah sudah lama terdeteksi pada kelelawar di Indonesia, tapi belum ada kasus infeksi pada manusia. ● Keterbatasan sistem deteksi dini berpotensi membuat kasus pada manusia tak ter...

Hidup tak seindah dracin: Ada delusi kemewahan dan propaganda, tapi penonton ketagihan

Beberapa contoh tayangan drama Cina.Dimas Mandegani/The Conversation Indonesia, CC BY● Genre drama Cina kerap dicap receh, penuh klise, tidak realistis, tapi mampu mencapai popularitas global.&#...

Agama, budaya, dan sistem: Riset ungkap mengapa laki-laki minim terlibat dalam pekerjaan rumah tangga

Tumpukan baju kotor pada keranjang(Shutterstock)● Perempuan masih menanggung beban kerja domestik lebih berat dari laki-laki, akibat norma dan kebijakan patriarki.● Agama memungkinkan tafs...